These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18959495)

  • 41. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 42. GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortality.
    Tillmann HL; Patel K; McHutchison JG
    Gastroenterology; 2008 Jun; 134(7):2191; author reply 2191-2. PubMed ID: 18485905
    [No Abstract]   [Full Text] [Related]  

  • 43. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertriglyceridemia in antiretroviral therapy.
    Imarhiagbe FA; Kubeyinje EP
    MedGenMed; 2005 Sep; 7(3):65. PubMed ID: 16369291
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiretroviral therapy and the prevalence and incidence of diabetes.
    Mikhail N; Cope D
    Arch Intern Med; 2005 Nov; 165(21):2536-7; author reply 2537. PubMed ID: 16314552
    [No Abstract]   [Full Text] [Related]  

  • 46. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New spectrum of HIV-associated cognitive disorders in the HAART era].
    Du Pasquier R; Cavassini M; Simioni S; Annoni JM; Giacobini E; Hirschel B
    Rev Med Suisse; 2009 Apr; 5(201):955-6, 958-61. PubMed ID: 19476058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical management of HIV/hepatitis C virus coinfection.
    Pozza R
    J Am Acad Nurse Pract; 2008 Oct; 20(10):496-505. PubMed ID: 19128345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
    Young J; Glass TR; Bernasconi E; Rickenbach M; Furrer H; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC;
    J Clin Epidemiol; 2009 Jun; 62(6):632-41. PubMed ID: 19108985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute kidney injury in patients with human immunodeficiency virus infection.
    Cohen SD; Chawla LS; Kimmel PL
    Curr Opin Crit Care; 2008 Dec; 14(6):647-53. PubMed ID: 19005305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.
    Crane M; Oliver B; Matthews G; Avihingsanon A; Ubolyam S; Markovska V; Chang JJ; Dore GJ; Price P; Visvanathan K; French M; Ruxrungtham K; Lewin SR
    J Infect Dis; 2009 Apr; 199(7):974-81. PubMed ID: 19231993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.
    Sungkanuparph S; Wongprasit P; Manosuthi W; Atamasirikul K
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):863-6. PubMed ID: 19058581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients.
    Khalili H; Dashti-Khavidaki S; Mohraz M; Etghani A; Almasi F
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):848-57. PubMed ID: 19551698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gingival ulcers as first manifestation of leishmaniasis and HIV infection.
    Montineri A; La Rosa R; Larocca L; Brisolese V; Brancati G; Fatuzzo F; Nigro L
    AIDS; 2008 Jan; 22(1):160-1. PubMed ID: 18090409
    [No Abstract]   [Full Text] [Related]  

  • 56. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased cardiovascular risk in patients with human immunodeficiency virus infection under highly active antiretroviral therapy.
    Zangerle R; Fuchs D
    Am J Cardiol; 2008 Aug; 102(3):373-4. PubMed ID: 18638612
    [No Abstract]   [Full Text] [Related]  

  • 58. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of the patient with HIV disease.
    Sharma SK; Kadhiravan T
    Dis Mon; 2008 Mar; 54(3):162-95. PubMed ID: 18294976
    [No Abstract]   [Full Text] [Related]  

  • 60. Early versus deferred antiretroviral therapy for HIV.
    Gelinck LB; van der Ende ME
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.